April 24 – 26, 2023 | Amsterdam, Netherlands
Supercharge the Clinical Translation of Efficacious Neoantigen Vaccines & Immunotherapies for Patients in Need
The 6th Annual Neoantigen Summit Europe returns to Amsterdam, as the only summit in Europe dedicated to advancing exclusive tumour antigen discovery and personalised therapeutic development within the world of immunotherapy.
- Examine critical factors for successful translation of personalised therapies into the clinic with Geneos Therapeutics, Curvac, Transgene, Nykode Therapeutics and Immunetune
- Enhance various methods to increasing the precision accuracy of identifying neoantigens with The Netherlands Cancer Institute and Precision BioLogic
- Delve into the how to overcome specific challenges in vaccine manufacturing for targeting neoantigens with BioNTech
Join 150+ experts at the forum, including Beacon’s Cancer Vaccine Research Lead, Megan Taylor, as they navigate validation of neoantigen targets and review methodologies/technologies to support with translating neoantigen-based studies effectively to the clinic.
